Cited by 308Thyroid Disorders and TreatmentsCardiovascular Function and Risk FactorsHormonal and reproductive studies

Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study

Open access
Monzani, Fabio, Di Bello, Vitantonio, Caraccio, Nadia, Bertini, Alessio, Giorgi, Davide, Giusti, Costantino, Ferrannini, Ele·2001·The Journal of Clinical Endocrinology & Metabolism

Abstract

Subclinical hypothyroidism (sHT) affects 5-15% of the general population; however, the need of lifelong L-T(4) therapy is still controversial. As myocardium is a main target of thyroid hormone action, we investigated whether sHT induces cardiovascular alterations. Twenty sHT patients were randomly assigned to receive placebo or L-T(4) therapy and were followed for 1 yr. Twenty sex- and age-matched normal subjects served as controls. Doppler echocardiography and videodensitometric analysis were performed in all subjects. Myocardium textural parameters were obtained as mean gray levels, which were then used to calculate the cyclic variation index (CVI; percent systolic/diastolic change in mean gray levels). Patients had a significantly higher isovolumic relaxation time (3.1 +/- 0.5 vs. 2.6 +/- 0.6; P < 0.03), peak A (0.77 +/- 0.16 vs. 0.56 +/- 0.13 m/s; P < 0.01), and preejection/ejection time (PEP/ET) ratio (0.72 +/- 0.05 vs. 0.57 +/- 0.06; P < 0.03) and a lower CVI (P < 0.0001) than controls. CVI was inversely related to TSH level (P < 0.0001) and PEP/ET ratio (P < 0.01). L-T(4)-treated patients showed a significant reduction of the PEP/ET ratio (P < 0.05), peak A (P < 0.05), and isovolumic relaxation time (P < 0.05) along with a normalization of CVI. Conversely, no changes were observed in the placebo-treated group. In conclusion, sHT affects both myocardial structure and contractility. These alterations may be reversed by L-T(4) therapy.

Integrity signals

Registry

Crossref · 10.1210/jcem.86.3.7291

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RCTs have demonstrated that LT4 replacement therapy affects myocardial function, particularly diastolic function, and over time the brachial artery intimal thickness.

    “Similarly, RCTs have demonstrated that LT4 replacement therapy affects myocardial function (87) and particularly diastolic function (88-92), and, over time, the brachial artery intimal thickness (89,93).”
  • Trials of levothyroxine in subclinical hypothyroidism using surrogate markers have shown improvement in left ventricular function, vascular endothelial function, atherogenic lipid particles, or cardiac mitochondrial function.

    “Trials of levothyroxine in SCH using surrogate markers have shown improvement in LV function, vascular endothelial function, atherogenic lipid particles, or cardiac mitochondrial function (4,91,105-108).”

    From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [107]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Monzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E.
Affiliations
University of Pisa (IT)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2001-03
Volume
86
Issue
3
Pages
1110-1115
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2123066698
Cited by
308
References
36
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 11 · 2022: 8 · 2021: 11 · 2020: 20 · 2019: 12 · 2018: 15 · 2017: 15 · 2016: 14 · 2015: 10 · 2014: 14 · 2013: 20 · 2012: 16
FWCI
7.58
Type
journal article
Language
en
Licence
other-oa
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
subclinical hypothyroidism, levothyroxine, thyroid hormone replacement, cardiac function, cardiac contractility, isovolumic relaxation time, myocardial texture, thyroid-stimulating hormone, Doppler echocardiography, videodensitometry
MeSH terms
Adult, Diastole, Double-Blind Method, Female, Heart, Humans, Hypothyroidism, Image Processing, Computer-Assisted, Male, Myocardium, Placebos, Systole, Thyrotropin, Thyroxine, Triiodothyronine, Videotape Recording, Echocardiography, Doppler

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review